全球活細胞成像市場
市場調查報告書
商品編碼
1545633

全球活細胞成像市場

Global Live Cell Imaging Market

出版日期: | 出版商: BCC Research | 英文 130 Pages | 訂單完成後即時交付

價格

全球活細胞成像市場規模預計將從 2024 年的 29 億美元增加到 2029年終的 43 億美元,預測期內複合年成長率為 8.4%。

北美市場預計將從2024年的11億美元成長到2029年終的17億美元,複合年成長率為8.3%。此外,亞太市場預計將從2024年的7.573億美元成長到2029年底的12億美元,複合年成長率為9.2%。

本報告調查了全球活細胞成像市場,並提供了市場概況、市場影響因素和市場機會分析、新興技術和技術發展趨勢、市場規模趨勢和預測,以及各個細分市場和地區的詳細分析、競爭格局、主要企業簡介等

目錄

第1章執行摘要

  • 市場展望
  • 調查範圍
  • 市場概況

第2章 市場概況

  • 概述
  • 活細胞成像的歷史與方法
  • 微電影攝影
  • 相差顯微鏡
  • 數位相機和現代成像技術
  • 前景
  • 供應鏈分析

第3章市場動態

  • 市場動態
  • 市場促進因素
  • 在藥物發現中擴大高內涵篩檢技術的採用
  • 對提高對細胞過程的理解的需求不斷成長
  • 增加研究經費的可用性
  • 市場限制因素
  • 科學設備成本高成本
  • 市場機會
  • 新興國家擴大採用活細胞成像
  • 成像技術的進步
  • 市場挑戰
  • 維持細胞培養中的細胞環境
  • 影像分析和資料管理

第 4 章 新興科技與當前趨勢

  • 活細胞成像的最新趨勢
  • 超高解析度顯微鏡
  • 光片顯微鏡
  • 3D成像
  • 檢測器和成像方法的進步
  • 新興技術
  • 深度學習和人工智慧
  • 遠端活細胞成像系統
  • 奈米級解析度的活細胞成像

第5章市場區隔分析

  • 細分細分
  • 市場區隔: 按組件
  • 設備/軟體
  • 消耗品
  • 服務
  • 市場區隔:依技術分類
  • 延時顯微鏡
  • 螢光共振能量轉移 (FRET)
  • 光漂白後的螢光恢復 (FRAP)
  • 高內涵篩檢(HCS)
  • 其他
  • 市場區隔:按最終用戶
  • 製藥和生物技術公司
  • 學術研究所
  • CRO
  • 地域分佈
  • 北美洲
  • 歐洲
  • 亞太地區
  • 其他

第6章 競爭訊息

  • 企業市場占有率分析
  • 廠商招募策略

第 7 章活細胞影像市場的永續性:ESG 視角

  • 概述
  • 光源
  • 連網型的電腦
  • 資料儲存
  • 遠端監控分析
  • 系統複雜度
  • ESG觀點
  • 環境影響
  • 社會影響
  • 管治

第8章附錄

  • 調查方法
  • 來源
  • 縮寫詞
  • 公司簡介
  • AGILENT TECHNOLOGIES INC.
  • BD
  • BIO-RAD LABORATORIES INC.
  • BRUKER
  • CARL ZEISS AG
  • DANAHER CORP.
  • EVIDENT
  • NIKON INSTRUMENTS INC.
  • REVVITY
  • SARTORIUS AG
  • THERMO FISHER SCIENTIFIC INC.
Product Code: BIO256A

The global market for live cell imaging is expected to grow from $2.9 billion in 2024 and is projected to reach $4.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.

The North American market for live cell imaging is expected to grow from $1.1 billion in 2024 and is projected to reach $1.7 billion by the end of 2029, at a CAGR of 8.3% during the forecast period of 2024 to 2029.

The Asia-Pacific market for live cell imaging is expected to grow from $757.3 million in 2024 and is projected to reach $1.2 billion by the end of 2029, at a CAGR of 9.2% during the forecast period of 2024 to 2029.

Report Scope:

This report covers the worldwide market for live cell imaging, which consists of various instruments, consumables, software and services offered by companies operating in the market. Based on components, the market is divided into instruments and software, consumables and services. By technology, the market is segmented into time-lapse microscopy, fluorescence resonance energy transfer (FRET), fluorescence recovery after photobleaching (FRAP), high-content screening (HCS) and other technologies. Based on end users, it is divided into pharmaceutical and biotechnology companies, academic research institutes and contract research organizations.

By geography, the market in this report is divided into four regions: North America, Europe, Asia-Pacific and Rest of the World (RoW). For market estimates, data has been provided for 2023 as the base year, with forecasts for 2024 through 2029.

The report also covers supply chain analysis, innovative research, opportunities within the market and profiles of leading companies in the live cell imaging industry.

Report Includes:

  • 54 data tables and 37 additional tables
  • An overview of the current and potential global markets for live cell imaging technologies
  • Analyses of global market trends, with market revenue data from 2021 to 2023, estimates for 2024, and projected CAGRs through 2029
  • Estimates of the current market size and revenue prospects, along with a market share analysis based on components, technology, end-user and region
  • Facts and figures pertaining to the market dynamics, current and emerging technologies, the global supply chain and the expected impact of macroeconomic factors
  • Analysis of the current state of live cell imaging devices, their application in cell labs, and the technologies used in the devices to address specific research needs
  • Overview of ESG developments and sustainability trends, with a focus on consumer attitudes, companies' ESG score rankings and their ESG practices
  • Insight into the current industry structure, including company revenue share analysis, mergers and acquisitions, and venture funding
  • Company profiles including, Danaher Corp., Zeiss Group, Nikon Instruments Inc., Evident, and Thermo Fisher Scientific Inc.

Table of Contents

Chapter 1 Executive Summary

  • Market Outlook
  • Scope of Report
  • Market Summary

Chapter 2 Market Overview

  • Overview
  • History and Methods of Live Cell Imaging
  • Microcinematography
  • Phase Contrast Microscopy
  • Digital Camera and Modern Imaging Techniques
  • Future Perspectives
  • Supply Chain Analysis

Chapter 3 Market Dynamics

  • Market Dynamics
  • Market Drivers
  • Growing Adoption of High-Content Screening Techniques in Drug Discovery
  • Increasing Demand for Improved Understanding of Cellular Processes
  • Growing Availability of Research Funds
  • Market Restraints
  • High Cost of Scientific Instruments
  • Market Opportunities
  • Increasing adoption of Live Cell Imaging in Emerging Nations
  • Advances in Imaging Technologies
  • Market Challenges
  • Maintaining Cellular Environment in Cell Culture
  • Image Analysis and Data Management

Chapter 4 Emerging Technologies and Current Trends

  • Current Trends in Live Cell Imaging
  • Super-Resolution Microscopy
  • Light Sheet Microscopy
  • 3D Imaging
  • Advances in Detectors and Imaging Modalities
  • Emerging Technologies
  • Deep learning and AI
  • Remote Live Cell Imaging System
  • Live Cell Imaging at Nanoscale Resolution

Chapter 5 Market Segmentation Analysis

  • Segmentation Breakdown
  • Market Segmentation by Components
  • Instruments and Software
  • Consumables
  • Services
  • Market Segmentation, by Technology
  • Time-Lapse Microscopy
  • Fluorescence Resonance Energy Transfer (FRET)
  • Fluorescence Recovery After Photobleaching (FRAP)
  • High-Content Screening (HCS)
  • Other Technologies
  • Market Segmentation by End User
  • Pharmaceutical and Biotechnology Companies
  • Academic Research Institutes
  • Contract Research Organizations
  • Geographic Breakdown
  • North America
  • Europe
  • Asia-Pacific
  • Rest of World

Chapter 6 Competitive Intelligence

  • Company Share Analysis
  • Strategies Adopted by Manufacturers

Chapter 7 Sustainability in Live Cell Imaging Market: ESG Perspective

  • Overview
  • Light Source
  • Connected Computer
  • Data Storage
  • Remote Monitoring and Analysis
  • System Complexity
  • ESG Perspective
  • Environmental Impact
  • Social Impact
  • Governance

Chapter 8 Appendix

  • Methodology
  • Sources
  • Acronyms
  • Company Profiles
  • AGILENT TECHNOLOGIES INC.
  • BD
  • BIO-RAD LABORATORIES INC.
  • BRUKER
  • CARL ZEISS AG
  • DANAHER CORP.
  • EVIDENT
  • NIKON INSTRUMENTS INC.
  • REVVITY
  • SARTORIUS AG
  • THERMO FISHER SCIENTIFIC INC.

List of Tables

  • Summary Table : Global Market for Live Cell Imaging, by Region, Through 2029
  • Table 1 : List of Few Commercially Available Live Cell Imaging Probes, Applications and Vendors
  • Table 2 : Global Market for Live Cell Imaging, by Components, Through 2029
  • Table 3 : Global Market for Live Cell Imaging Instruments and Software, by Region, Through 2029
  • Table 4 : Global Market for Live Cell Imaging Consumables, by Region, Through 2029
  • Table 5 : Global Market for Live Cell Imaging Services, by Region, Through 2029
  • Table 6 : Global Market for Live Cell Imaging, by Technology, Through 2029
  • Table 7 : Global Market for Time-Lapse Microscopy, by Region, Through 2029
  • Table 8 : Global Market for Fluorescence Resonance Energy Transfer, by Region, Through 2029
  • Table 9 : Global Market for Fluorescence Recovery After Photobleaching, by Region, Through 2029
  • Table 10 : Global Market for High-Content Screening, by Region, Through 2029
  • Table 11 : Global Market for Other Technologies in Live Cell Imaging, by Region, Through 2029
  • Table 12 : Global Market for Live Cell Imaging, by End User, Through 2029
  • Table 13 : Global Market for Pharmaceutical and Biotechnology Companies Using Live Cell Imaging, by Region, Through 2029
  • Table 14 : A Few Academic Research Institute Using Live Cell Imaging Research
  • Table 15 : Global Market for Academic Research Institutes Using Live Cell Imaging, by Region, Through 2029
  • Table 16 : A Few Contract Research Organizations Using Live Cell Imaging
  • Table 17 : Global Market for Contract Research Organizations Using Live Cell Imaging, by Region, Through 2029
  • Table 18 : Global Market for Live Cell Imaging, by Region, Through 2029
  • Table 19 : North American Market for Live Cell Imaging, by Country, Through 2029
  • Table 20 : North American Market for Live Cell Imaging, by Components, Through 2029
  • Table 21 : North American Market for Live Cell Imaging, by Technology, Through 2029
  • Table 22 : North American Market for Live Cell Imaging, by End User, Through 2029
  • Table 23 : U.S. Market for Live Cell Imaging, Through 2029
  • Table 24 : Canadian Market for Live Cell Imaging, Through 2029
  • Table 25 : Mexican Market for Live Cell Imaging, Through 2029
  • Table 26 : European Market for Live Cell Imaging, by Country, Through 2029
  • Table 27 : European Market for Live Cell Imaging, by Components, Through 2029
  • Table 28 : European Market for Live Cell Imaging, by Technology, Through 2029
  • Table 29 : European Market for Live Cell Imaging, by End User, Through 2029
  • Table 30 : German Market for Live Cell Imaging, Through 2029
  • Table 31 : U.K. Market for Live Cell Imaging, Through 2029
  • Table 32 : French Market for Live Cell Imaging, Through 2029
  • Table 33 : Spanish Market for Live Cell Imaging, Through 2029
  • Table 34 : Italian Market for Live Cell Imaging, Through 2029
  • Table 35 : Rest of European Market for Live Cell Imaging, Through 2029
  • Table 36 : Asia-Pacific Market for Live Cell Imaging, by Country, Through 2029
  • Table 37 : Asia-Pacific Market for Live Cell Imaging, by Components, Through 2029
  • Table 38 : Asia-Pacific Market for Live Cell Imaging, by Technology, Through 2029
  • Table 39 : Asia-Pacific Market for Live Cell Imaging, by End User, Through 2029
  • Table 40 : Chinese Market for Live Cell Imaging, Through 2029
  • Table 41 : Japanese Market for Live Cell Imaging, Through 2029
  • Table 42 : Indian Market for Live Cell Imaging, Through 2029
  • Table 43 : South Korean Market for Live Cell Imaging, Through 2029
  • Table 44 : Rest of Asia-Pacific Market for Live Cell Imaging, Through 2029
  • Table 45 : Rest of the World Market for Live Cell Imaging, by Components, Through 2029
  • Table 46 : Rest of the World Market for Live Cell Imaging, by Technology, Through 2029
  • Table 47 : Rest of the World Market for Live Cell Imaging, by End User, Through 2029
  • Table 48 : Report Sources
  • Table 49 : Glossary of Terms Used in Global Live Cell Imaging Market
  • Table 50 : Agilent Technologies Inc.: Company Snapshot
  • Table 51 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
  • Table 52 : Agilent Technologies Inc.: Product Portfolio
  • Table 53 : Agilent Technologies Inc: News/Key Developments, 2023
  • Table 54 : BD: Company Snapshot
  • Table 55 : BD: Financial Performance, FY 2022 and 2023
  • Table 56 : BD: Product Portfolio
  • Table 57 : BD: News/Key Developments, 2023
  • Table 58 : Bio-Rad Laboratories Inc.: Company Snapshot
  • Table 59 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
  • Table 60 : Bio-Rad Laboratories Inc.: Product Portfolio
  • Table 61 : Bruker: Company Snapshot
  • Table 62 : Bruker: Financial Performance, FY 2022 and 2023
  • Table 63 : Bruker: Product Portfolio
  • Table 64 : Bruker: News/Key Developments, 2024
  • Table 65 : Carl Zeiss AG: Company Snapshot
  • Table 66 : Carl Zeiss AG: Financial Performance, FY 2022 and 2023
  • Table 67 : Carl Zeiss AG: Product Portfolio
  • Table 68 : Carl Zeiss AG: News/Key Developments, 2024
  • Table 69 : Danaher Corp.: Company Snapshot
  • Table 70 : Danaher Corp.: Financial Performance, FY 2022 and 2023
  • Table 71 : Danaher Corp.: Product Portfolio
  • Table 72 : Danaher Corp.: News/Key Developments, 2024
  • Table 73 : Evident: Company Snapshot
  • Table 74 : Evident: Product Portfolio
  • Table 75 : Evident: News/Key Developments, 2023
  • Table 76 : Nikon Instruments Inc.: Company Snapshot
  • Table 77 : Nikon Instruments Inc.: Product Portfolio
  • Table 78 : Nikon Instruments Inc.: News/Key Developments, 2024
  • Table 79 : Revvity: Company Snapshot
  • Table 80 : Revvity: Financial Performance, FY 2022 and 2023
  • Table 81 : Revvity: Product Portfolio
  • Table 82 : Revvity: News/Key Developments, 2021
  • Table 83 : Sartorius AG: Company Snapshot
  • Table 84 : Sartorius AG: Financial Performance, FY 2022 and 2023
  • Table 85 : Sartorius AG: Product Portfolio
  • Table 86 : Sartorius AG: News/Key Developments, 2023
  • Table 87 : Thermo Fisher Scientific Inc.: Company Snapshot
  • Table 88 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
  • Table 89 : Thermo Fisher Scientific Inc.: Product Portfolio
  • Table 90 : Thermo Fisher Scientific Inc.: News/Key Developments, 2023

List of Figures

  • Summary Figure : Global Market for Live Cell Imaging, by Region, 2021-2029
  • Figure 1 : Cellular Imaging and Analysis Workflow
  • Figure 2 : Different Techniques Used in Live-Cell Imaging
  • Figure 3 : Supply Chain of Live Cell Imaging Market
  • Figure 4 : Market Dynamics of Global Live Cell Imaging Market
  • Figure 5 : Total Stem Cell Research Funding by the National Institutes for Health, 2013-2025
  • Figure 6 : Global Market Shares of Live Cell Imaging, by Components, 2023
  • Figure 7 : Global Market Shares of Live Cell Imaging, by Technology, 2023
  • Figure 8 : Global Market Shares of Live Cell Imaging, by End-user, 2023
  • Figure 9 : Global Market Shares of Live Cell Imaging, by Region, 2023
  • Figure 10 : North American Market Shares of Live Cell Imaging, by Country, 2023
  • Figure 11 : North American Market for Live Cell Imaging, by Components, 2021-2029
  • Figure 12 : North American Market for Live Cell Imaging, by Technology, 2021-2029
  • Figure 13 : North American Market for Live Cell Imaging, by End User, 2021-2029
  • Figure 14 : U.S. Market for Live Cell Imaging, 2021-2029
  • Figure 15 : Canadian Market for Live Cell Imaging, 2021-2029
  • Figure 16 : Mexican Market for Live Cell Imaging, 2021-2029
  • Figure 17 : European Market Shares of Live Cell Imaging, by Country, 2023
  • Figure 18 : European Market for Live Cell Imaging, by Components, 2021-2029
  • Figure 19 : European Market for Live Cell Imaging, by Technology, 2021-2029
  • Figure 20 : European Market for Live Cell Imaging, by End User, 2021-2029
  • Figure 21 : German Market for Live Cell Imaging, 2021-2029
  • Figure 22 : U.K. Market for Live Cell Imaging, 2021-2029
  • Figure 23 : French Market for Live Cell Imaging, 2021-2029
  • Figure 24 : Spanish Market for Live Cell Imaging, 2021-2029
  • Figure 25 : Italian Market for Live Cell Imaging, 2021-2029
  • Figure 26 : Rest of European Market for Live Cell Imaging, 2021-2029
  • Figure 27 : Asia-Pacific Market Shares of Live Cell Imaging, by Country, 2023
  • Figure 28 : Asia-Pacific Market for Live Cell Imaging, by Components, 2021-2029
  • Figure 29 : Asia-Pacific Market for Live Cell Imaging, by Technology, 2021-2029
  • Figure 30 : Asia-Pacific Market for Live Cell Imaging, by End User, 2021-2029
  • Figure 31 : Chinese Market for Live Cell Imaging, 2021-2029
  • Figure 32 : Japanese Market for Live Cell Imaging, 2021-2029
  • Figure 33 : Indian Market for Live Cell Imaging, 2021-2029
  • Figure 34 : South Korean Market for Live Cell Imaging, 2021-2029
  • Figure 35 : Rest of Asia-Pacific Market for Live Cell Imaging, 2021-2029
  • Figure 36 : Rest of the World Market for Live Cell Imaging, by Components, 2021-2029
  • Figure 37 : Rest of the World Market for Live Cell Imaging, by Technology, 2021-2029
  • Figure 38 : Rest of the World Market for Live Cell Imaging, by End User, 2021-2029
  • Figure 39 : Global Market Shares of Live Cell Imaging, by Manufacturers, 2023
  • Figure 40 : Strategies Adopted, by Key Players
  • Figure 41 : Sustainability Factors for Live Cell Imaging
  • Figure 42 : Agilent Technologies Inc.: Revenue Shares, by Business Unit, FY 2023
  • Figure 43 : Agilent Technologies Inc.: Revenue Shares, by Country/Region, FY 2023
  • Figure 44 : BD: Revenue Shares, by Business Unit, FY 2023
  • Figure 45 : BD: Revenue Shares, by Country/Region, FY 2023
  • Figure 46 : Bio-Rad Laboratories Inc.: Revenue Shares, by Business Unit, FY 2023
  • Figure 47 : Bio-Rad Laboratories Inc.: Revenue Shares, by Country/Region, FY 2023
  • Figure 48 : Bruker: Revenue Shares, by Business Unit, FY 2023
  • Figure 49 : Bruker: Revenue Shares, by Country/Region, FY 2023
  • Figure 50 : Carl Zeiss AG: Revenue Shares, by Business Unit, FY 2023
  • Figure 51 : Carl Zeiss AG: Revenue Shares, by Country/Region, FY 2023
  • Figure 52 : Danaher Corp.: Revenue Shares, by Business Unit, FY 2023
  • Figure 53 : Danaher Corp.: Revenue Shares, by Country/Region, FY 2023
  • Figure 54 : Revvity: Revenue Shares, by Business Unit, FY 2023
  • Figure 55 : Revvity: Revenue Shares, by Country/Region, FY 2023
  • Figure 56 : Sartorius AG: Revenue Shares, by Business Unit, FY 2023
  • Figure 57 : Sartorius AG: Revenue Shares, by Country/Region, FY 2023
  • Figure 58 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2023
  • Figure 59 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2023